Market research
ESTA Establishment Labs Holdings Inc
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 98.5
- Dividend yield
- Not available
- Beta
- 1.06
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- VGG312491084
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 98.5
- Dividend yield
- Not available
- Beta
- 1.06
About
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Research context
Establishment Labs Holdings Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ESTA discussion.
5 years, 6 months ago
Establishment Labs Holdings Inc is currently in a long term uptrend where the price is trading 53.8% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.2.
Establishment Labs Holdings Inc's total revenue rose by 11.2% to $27M since the same quarter in the previous year.
Its net income has dropped by 1.6% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 142.9% to $2M since the same quarter in the previous year.
Based on the above factors, Establishment Labs Holdings Inc gets an overall score of 4/5.